What smart money is saying about Waters Corp
2 funds in our archive have pitched Waters Corp — most recently Artisan U.S. Mid-Cap Growth Strategy in December 2025.
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.
Get an email when a fund writes about it
Position history
Between Q1 2025 and Q2 2026, 10 fund letters reported a position in Waters Corp — 7 trimmed or exited.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 6 | 0 | 5 | 0 |
| Q1 2026 | 4 | 0 | 2 | 0 |
| Q4 2025 | 0 | 0 | 0 | 1 |
| Q1 2025 | 0 | 0 | 0 | 1 |
Fund activity · 10 positions · 7 moves
- June 2026
“We eliminated the following position(s) during the period: • Akzo Nobel • Charter Communications Cl A • Roche Holding • Waters”
Waters Corp - June 2026
“We also exited the small position in Waters we had received following its spinoff from Becton Dickinson in the first quarter.”
Waters Corp - HoldsFindlay Park American FundJune 2026
“Beyond semiconductors, the contributor list was more varied. West Pharmaceutical Services and Waters benefited from accelerating organic revenue growth and improved guidance.”
Waters Corp - June 2026
“We eliminated the following position(s) during the period:”
Waters Corp - June 2026
“Waters Corporation was also eliminated.”
Waters Corp - June 2026
“Waters Corporation was also eliminated.”
Waters Corp - March 2026
“ Waters Corporation (WAT) purchased the Biosciences & Diagnostic Solutions business from Becton, Dickinson & Co. (BDX) through a Reverse Morris Trust structure in a deal that closed in early February. Through our ownership of BDX we received shares of WAT stock upon the deal closure. We sold our shares in WAT and used the proceeds to add to our existing position in BDX.”
Waters Corp - March 2026
“Vertex Pharmaceuticals Inc. United States 2.4 Biotechnology Waters Corporation United States 0.3 Life Sciences Tools & Services”
Waters Corp - March 2026
Listed in Hardman Johnston Select Equity’s reported holdings.
Waters Corp - Exited1578 Partners, LPMarch 2026
“We sold the shares of WAT we received.”
Waters Corp
Fund coverage · 2 theses
- Artisan U.S. Mid-Cap Growth StrategyDecember 2025
Waters provides chromatography and mass spectrometry tools with strong recurring revenue and tailwinds from pharma demand, replacement cycles and biologics exposure.
Read the full thesis - Baron Health Care FundMarch 2025
Waters Corporation is a leading provider of analytical instruments with a strong market position in biopharmaceutical quality control, poised for growth driven by various factors, including new regulations and increased demand in multiple sectors.
Read the full thesis
Read every full thesis on Waters Corp
Unlock all 2 theses — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→